You searched for Antibody candidate - Page 64 of 69

Novartis Cardiovascular Canakinumab Phase III

News and Trends 22 Jun 2017

Novartis Scores Major Phase III Win with New Cardiovascular Drug

…in one of the largest and longest-running Phase III trials in the company’s history. Canakinumab is a fully human monoclonal antibody that inhibits IL-1ß, a key cytokine in the inflammatory…

June 22, 2017 - 2 minutesmins - By Melanie De Almeida

Best in Biotech 4 Nov 2019

Top 10 Biotech Companies Leaving a Mark in Munich

…biotech industry. MorphoSys Morphosys is one of just a few biotech companies in Europe valued at over €1Bn. Founded in 1992, the company specializes in the development of antibody treatments…

November 4, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

Sanofi regeneron rheumatoid arthritis salurimab

News and Trends 31 Oct 2016

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

…improvement in physical function of patient joints. There is a strong competition for antibody research into chronic auto-immune diseases such as Rheumatoid. A few Biotech giants are extra anxious to…

October 31, 2016 - 3 minutesmins - By Dani Bancroft

In Depth 2 Jan 2018

The Labiotech Dictionary of Important Biotech Terms

…up to the immune system for destruction. The structure of an antibody, which allows it to bind dangerous pathogens, fight infection and stimulate an immune response. Some of Europe’s best…

January 2, 2018 - 14 minutesmins - By Alex Dale

News and Trends 16 Sep 2022

Marengo advancing its lead TCR activator into clinic after FDA clearance

…a bi-functional fusion antibody that deploys a mechanism of T cell activation that has demonstrated potent single agent activity in PD-1 refractory settings in preclinical studies. Marengo Therapeutics plans to…

September 16, 2022 - 2 minutesmins - By Liza Laws

adc therapeutics genomics sophia genetics blood cancer

News and Trends 6 Aug 2019

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

…who will respond best to the drug. No financial details of the deal were disclosed. ADC Therapeutics’ drug is an antibody that is chemically joined to a molecule that kills…

August 6, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 27 Jan 2023

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

…beta (Aβ) protofibril antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia) with confirmed amyloid pathology, for review following…

January 27, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 21 Mar 2023

5 advancements in Down syndrome research over the past year

…studies have shown that people with Down syndrome have a hyperactivated CB1 cannabinoid receptor, the drug candidate is based on the modulation of the receptor with specific inhibitors which has…

March 21, 2023 - 8 minutesmins - By Roohi Mariam Peter

Startup Scout 31 Jan 2020

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

…that are investigating glycans as a brand new target for cancer immunotherapies. CellmAbs’ lead candidate is an antibody drug designed to block aberrant glycans on cancer cells. Blocking these aberrant…

January 31, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 3 May 2023

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline

…decline, respectively. The incidence of amyloid-related imaging abnormalities (ARIA) was consistent with the TRAILBLAZER-ALZ phase 2 study. ARIA is observed with the amyloid plaque clearing antibody class of therapies and…

May 3, 2023 - 8 minutesmins - By Jim Cornall

Startup Scout 21 Feb 2020

This Startup is Developing Anti-Aging Antibodies

The Heidelberg-based startup Velabs Therapeutics aims to make anti-aging drugs that selectively destroy ‘aged’ cells in the body. Mission: To develop antibody drugs using microfluidics technology that can kill old…

February 21, 2020 - 4 minutesmins - By Jonathan Smith

In Depth 5 Nov 2024

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

…as ANB033 (anti-CD122 antagonist antibody) entering a phase 1 trial, and ANB101 (BDCA2 modulator antibody) in preclinical development. Moreover, just after it announced it wanted to separate its consumer health…

November 5, 2024 - 9 minutesmins - By Jules Adam

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Novartis Scores Major Phase III Win with New Cardiovascular Drug

Top 10 Biotech Companies Leaving a Mark in Munich

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

The Labiotech Dictionary of Important Biotech Terms

Marengo advancing its lead TCR activator into clinic after FDA clearance

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

5 advancements in Down syndrome research over the past year

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline

This Startup is Developing Anti-Aging Antibodies

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!